Glynn Wilson

Director at Cadrenal Therapeutics.

Earliest Form D on file: Apr 2026

2 filings at 1 company

Cadrenal Therapeutics

Biotech, Ponte Vedra FL

Director

Biotech, Ponte Vedra FL

Signed
Named
Size is amount sold, up to $30M

Filings

2

Jul 15, 2026
Option to acquire, security to be acquired, named · Form D
$8.8M
of $8.8M
Jul 15, 2026
Option to acquire, security to be acquired
Named, Director
$8.8M
$8.8M
Form D
Apr 6, 2026
Option to acquire, security to be acquired, named · Form D
$7.9M
of $7.9M
Apr 6, 2026
Option to acquire, security to be acquired
Named, Director
$7.9M
$7.9M
Form D

Network

At Cadrenal Therapeutics

8 people

Quang X. Pham
Together on 2 filings
Executive Officer, Director, signed as Chairman of the Board Chief Executive Officer
James J. Ferguson
Together on 2 filings
Executive Officer
Jeffrey S. Cole
Together on 2 filings
Executive Officer
John R. Murphy
Together on 2 filings
Director
Lee Golden
Together on 2 filings
Director
John P. Sharp
Together on 1 filing
Executive Officer

2 more at Cadrenal Therapeutics